Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2971121 | The Journal of Heart and Lung Transplantation | 2012 | 8 Pages |
Abstract
Compared with cyclosporine, de novo tacrolimus use was found to be associated with a significantly reduced risk for BOS Grade â¥1 at 3 years despite a similar rate of acute rejection. However, no survival advantage was detected.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hendrik MD, Allan R. MBBS, MD, Walter MD, Christina Aboyoun, Eik Vettorazzi, Raffael MD, Carlos MD, Christiane MD, John-David MD, Hermann MD, PhD,